Ask AI

Precision Payload: ADCs for Solid Tumors and the Essential Role of Oncology Pharmacists in TRAE Identification and Management

With increasing use of antibody–drug conjugates (ADCs) for the treatment of various tumor types, it is important to know how to manage treatment-related adverse events (TRAEs). Learners will be able to identify and manage TRAEs, tailor individual treatment plans, and discuss the mechanisms by which ADCs contribute to different safety profiles.

Share

Program Content

Activities

Current and Emerging ADCs
Introduction to ADCs in Solid Tumors: Basics, Relevance, and Current & Emerging Targeted Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2025

Expires: November 11, 2025

ADC AE Management
ADC AE Identification, Management, and Communication/Care Coordination
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2025

Expires: November 11, 2025

ADCs in Solid Tumors Pharmacy Perspective
Insight on Safety and Efficacy of ADCs in Solid Tumors: Focus on the Role of Oncology Pharmacists in Adverse Event Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2025

Expires: January 08, 2026

Activities

ADCs in Solid Tumors
What Oncology Pharmacists Need to Know About ADCs in Solid Tumor Management
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2025

Expires: December 26, 2025

Activities

ADCs in Solid Tumors Pharmacy Perspective
Insight on Safety and Efficacy of ADCs in Solid Tumors: Focus on the Role of Oncology Pharmacists in Adverse Event Management
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2025

Expires: January 08, 2026

Provided by

ProCE Banner

Provided by ProCE, LLC in collaboration with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner